Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
Plos Computational Biology|July 17, 2007
Optimal timing and duration of induction therapy for HIV-1 infectionMarcel E Curlin, Shyamala Iyer, John E MittlerBioinformatics (Oxford, England)|September 13, 2011
HIV Therapy Simulator: a graphical user interface for comparing the effectiveness of novel therapy regimensHuat Chye Lim, Marcel E Curlin, John E MittlerDiagnostics (Basel, Switzerland)|May 24, 2024
Comparative Performance of COVID-19 Test Methods in Healthcare Workers during the Omicron WaveEmma C Tornberg, Alexander Tomlinson, Nicholas T T Oshiro, et al.Emerging Infectious Diseases|April 26, 2024
Evaluating Humoral Immunity Elicited by XBB.1.5 Monovalent COVID-19 VaccineXammy Huu Nguyenla, Timothy A Bates, Mila Trank-Greene, et al.Scientific Reports|August 25, 2022
Bimodal distribution pattern associated with the PCR cycle threshold (Ct) and implications in COVID-19 infectionsDoris Yang, Donna E Hansel, Marcel E Curlin, et al.Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Immune imprinting and vaccination interval underly XBB.1.5 monovalent vaccine immunogenicityXammy H Wrynla, Timothy A Bates, Mila Trank-Greene, et al.Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
Omicron neutralizing antibody response following booster vaccination compared with breakthrough infectionMarcel E Curlin, Timothy A Bates, Gaelen Guzman, et al.Communications Medicine|May 17, 2025
Immune imprinting and vaccine interval determine antibody responses to monovalent XBB.1.5 COVID-19 vaccinationXammy Huu Wrynla, Timothy A Bates, Mila Trank-Greene, et al.Med (New York, N.Y.)|October 5, 2022
Omicron neutralizing antibody response following booster vaccination compared with breakthrough infectionMarcel E Curlin, Timothy A Bates, Gaelen Guzman, et al.Plos Pathogens|December 29, 2010
HIV-1 envelope subregion length variation during disease progressionMarcel E Curlin, Rafael Zioni, Stephen E Hawes, et al.Pageof 7